Rabbit anti-Human Lipoprotein Receptor-related Protein 6, Low Density Polyclonal Antibody | anti-LRP2 antibody

Lipoprotein Receptor-related Protein 6, Low Density, phosphorylated (S1490) (LRP6, FLJ90062, FLJ90421)

Cat. Num. AAA647244

• Gene Names: LRP2; DBS; GP330
• Reactivity: Human
• Applications: Western Blot
• Purity: Affinity Purified; Purified by immunoaffinity chromatography.
• Synonyms: Lipoprotein Receptor-related Protein 6; Low Density; Polyclonal Antibody; phosphorylated (S1490) (LRP6; FLJ90062; FLJ90421); Anti -Lipoprotein Receptor-related Protein 6; anti-LRP2 antibody

• Host: Rabbit
• Reactivity: Human
• Clonality: Polyclonal
• Isotype: IgG
• Specificity: Recognizes human LRP-6, when phosphorylated at LRP-6.
• Purity/Purification: Affinity Purified; Purified by immunoaffinity chromatography.
• Form/Format: Supplied as a lyophilized powder in PBS, sodium azide, trehalose. Reconstitute with sterile PBS to 200ug/ml.

• Applicable Applications for anti-LRP2 antibody: Western Blot (WB)
• Application Notes: Suitable for use in Western Blot.; Dilution: Western Blot: 1ug/ml
• Immunogen: Synthetic peptide corresponding to human LRP-6 S1490.
• Preparation and Storage: Lyophilized powder may be stored at -20 degree C. Stable for 12 months at -20 degree C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Reconstituted product is stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Western Blot (WB)

(Detection of Human Phospho­LRP­6 (S1490) by Western Blot. Western blot shows lysates of 293T human embryonic kidney cell line transfectedwith humanLRP­6untreated(­) or treated (+) with 100 ng/mL Recombinant Human Wnt­3a (High Purity) for 15 minutes. PVDF Membrane was probed with 1ug/ml of Rabbit Human Phospho­LRP­6 (S1490) Antigen Affinity­purified Polyclonal Antibody followed by HRP­ conjugated Rabbit IgG Secondary Antibody. A specific band was detected for Phospho­LRP­6 (S1490) at approximately 200kD (as indicated). The phospho­specificity of this antibody was supported by decreased labeling following treatment with 300u/ml CIP for 1 hour. This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.)

Related Product Information for anti-LRP2 antibody

LRP6 (Low-density lipoprotein receptor-related protein 6) is a 200-210kD member of the LDLR family of proteins. It is widely expressed, and serves as a coreceptor for both Wnt and parathyroid hormone. In the Wnt system, LRP6 associates with select Fzd multipass receptors; in the PTH system, LRP6 complexes with PTHR1. Mature human LRP6 is a 1594aa type I transmembrane glycoprotein. It contains a 1351aa extracellular region (aa20-1370) plus a 220aa cytoplasmic domain (aa1394-1613). The cytoplasmic domain contains two palmitoylation sites, one ubiquitination residue, and multiple phosphorylation motifs. aa1490 is a key residue that impacts multiple activities. It undergoes both constitutive and receptor activation-induced phosphorylation. At least three enzymes likely act at this site, including PKA (associated with PTHR1), GSK-3 (associated with Fzd) and Cyclin Y/PFTK1 (associated with G2/M of the cell cycle). In general, Ser1490 phosphorylation results in b-catenin stabilization, followed by either gene transcription or b-catenin binding to centrosomes.

Product Categories/Family for anti-LRP2 antibody

Antibodies; Abs to Receptors

NCBI and Uniprot Product Information

• NCBI GI #: 126012573
• NCBI GeneID: 4036
• NCBI Accession #: NP_004516.2
• NCBI GenBank Nucleotide #: NM_004525.2
• UniProt Accession #: P98164; O00711; Q16215
• Molecular Weight: 521,958 Da
• NCBI Official Full Name: low-density lipoprotein receptor-related protein 2
• NCBI Official Synonym Full Names: low density lipoprotein receptor-related protein 2
• NCBI Official Symbol: LRP2
• NCBI Official Synonym Symbols: DBS; GP330
• NCBI Protein Information: low-density lipoprotein receptor-related protein 2; LRP-2; megalin; glycoprotein 330; calcium sensor protein; Heymann nephritis antigen homolog
• UniProt Protein Name: Low-density lipoprotein receptor-related protein 2
• Protein Family: Low-density lipoprotein receptor-related protein
• UniProt Gene Name: LRP2
• UniProt Synonym Gene Names: LRP-2; gp330
• UniProt Entry Name: LRP2_HUMAN

NCBI Description

The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]

Uniprot Description

Function: Acts together with cubilin to mediate HDL endocytosis

By similarity. May participate in regulation of parathyroid-hormone and para-thyroid-hormone-related protein release.

Subunit structure: Binds plasminogen, extracellular matrix components, plasminogen activator-plasminogen activator inhibitor type I complex, apolipoprotein E-enriched beta-VLDL, lipoprotein lipase, lactoferrin, CLU/clusterin and calcium. Forms a multimeric complex together with a receptor-associated protein (RAP). Binds to ankyrin-repeat family A protein 2 (ANKRA2). Interacts with LRP2BP. Interacts (via NPXY motif) with DAB2; the interaction is not affected by tyrosine phosphorylation of the NPXY motif. Ref.5 Ref.6 Ref.7 Ref.8

Subcellular location: Membrane; Single-pass type I membrane protein. Membrane › coated pit.

Tissue specificity: Absorptive epithelia, including renal proximal tubules.

Involvement in disease: Donnai-Barrow syndrome (DBS) [MIM:222448]: Rare autosomal recessive disorder characterized by major malformations including agenesis of the corpus callosum, congenital diaphragmatic hernia, facial dysmorphology, ocular anomalies, sensorineural hearing loss and developmental delay. The FOAR syndrome was first described as comprising facial anomalies, ocular anomalies, sensorineural hearing loss, and proteinuria. DBS and FOAR were first described as distinct disorders but the classic distinguishing features between the 2 disorders were presence of proteinuria and absence of diaphragmatic hernia and corpus callosum anomalies in FOAR. Early reports noted that the 2 disorders shared many phenotypic features and may be identical. Although there is variability in the expression of some features (e.g., agenesis of the corpus callosum and proteinuria), DBS and FOAR are now considered to represent the same entity.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.10

Sequence similarities: Belongs to the LDLR family.Contains 17 EGF-like domains.Contains 36 LDL-receptor class A domains.Contains 37 LDL-receptor class B repeats.